Jennifer Fonstad is a serial entrepreneur and veteran venture investor with over two decades of experience in early stage technology investing, including energy and digital health. Jennifer co-founded and leads the Owl Capital Group an early stage investment firm and earlier co-founded Aspect Ventures. She manages $450MM across these two firms. Jennifer also served as a Managing Director with Draper Fisher Jurvetson for 17 years where she helped grow the firm from $150M under management to over $3.5B. Jennifer's invested in 40 software and healthcare companies with 5 IPOs and 6 M&A exits including Athenahealth, Flurry, Nanostring. Sutro Bio, and the Real Real. She is also a co-founder of Broadway Angels, a San Francisco-based angel network with over 40 investments and 60 women members drawing from the VC and technology communities. Jennifer’s success as an investor has landed her on the Forbes Midas List twice and in 2016 she was named Deloitte’s “Venture Capitalist of the Year.” In 2017, ‘Working Mother’ named her one of “The 50 Most Powerful Moms.” She is a graduate, Cum Laude, from Georgetown University and holds an MBA with Distinction from the Harvard Business School. Prior to venture investing, Jennifer was a consultant with Bain & Company and spent a year teaching math to high school students in sub-Sahara(n) Africa. She is a lifetime member of the Council on Foreign Relations and a board member for the Mastercard Foundation, a $30 billion foundation working to create 30MM jobs in Africa by 2030. She also serves on the HBS Dean's Advisory Board, the Edwards Lifesciences Digital Health Advisory Board, and the HBS West Research Center. Her favorite role is as a mother of four children.